PositiveID Chairman and CEO William J. Caragol, called into to go over the business model and market for the Company’s exciting product lines. PositiveID Corporation (OTCBB: PSID) develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFS, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit

For more information on iglucose, please visit For sales and partnership opportunities, please contact Mary Ellen Harrison at 561-805-8028